Competing Risk of Death and ESRD in Incident CKD Patients
- Conditions
- Chronic Kidney Diseases
- Registration Number
- NCT03379571
- Lead Sponsor
- Central Hospital, Nancy, France
- Brief Summary
Although chronic kidney disease (CKD) affects a growing number of people, epidemiologic data on incident CKD in the general population are scarce. Screening strategies to increase early CKD detection have been developed.
Methods: From a community-based sample of 4,409 individuals residing in a well-defined geographical area, investigators determined the number of patients having a first serum creatinine value ≥1.7 mg/dL and present for at least 3 months that allowed us to calculate an annual incidence rate of CKD (stages 3 to 5). CKD (stages 3 to 5) was defined by estimated glomerular filtration rate (eGFR) \<60 mL/min/1.73 m2. Investigators also described the primary care, outcomes and risk factors associated with outcomes using competing risks analyses for these CKD patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 631
- >= 18 years
- first serum creatinine value ≥1.7 mg/dL reached after January 1st, 2004
- and present for at least 3 months
- residing in the given geographical area (the Urban Community of Greater Nancy (UCGN))
- <18 years
- prevalent CKD patient : CKD diagnosis before January 1st, 2004
- patients on dialysis or renal transplanted
- refusal of participation
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method annual incidence rate of CKD inclusion number of patients residing in a well-defined geographical area having a first serum creatinine value ≥1.7 mg/dL after January 1st, 2004 and still present for at least 3 months
- Secondary Outcome Measures
Name Time Method dialysis initiation through study completion, 6 year after study start number of dialysis initiation.
death through study completion, 6 year after study start number of death
management of CKD patients through study completion, 6 year after study start %patients referred to a nephrologist, decline of the renal function